CN117203194A - 用作sting激动剂的新型化合物及其用途 - Google Patents
用作sting激动剂的新型化合物及其用途 Download PDFInfo
- Publication number
- CN117203194A CN117203194A CN202280023908.7A CN202280023908A CN117203194A CN 117203194 A CN117203194 A CN 117203194A CN 202280023908 A CN202280023908 A CN 202280023908A CN 117203194 A CN117203194 A CN 117203194A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- group
- pharmaceutically acceptable
- acceptable salt
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/083783 | 2021-03-30 | ||
| CN2021083783 | 2021-03-30 | ||
| CN2021090945 | 2021-04-29 | ||
| CNPCT/CN2021/090945 | 2021-04-29 | ||
| CN2021111479 | 2021-08-09 | ||
| CNPCT/CN2021/111479 | 2021-08-09 | ||
| CNPCT/CN2021/128942 | 2021-11-05 | ||
| CN2021128942 | 2021-11-05 | ||
| CN2021130097 | 2021-11-11 | ||
| CNPCT/CN2021/130097 | 2021-11-11 | ||
| CNPCT/CN2021/138806 | 2021-12-16 | ||
| CN2021138806 | 2021-12-16 | ||
| CN2021143043 | 2021-12-30 | ||
| CNPCT/CN2021/143043 | 2021-12-30 | ||
| CN2022071548 | 2022-01-12 | ||
| CNPCT/CN2022/071548 | 2022-01-12 | ||
| PCT/CN2022/083557 WO2022206725A1 (en) | 2021-03-30 | 2022-03-29 | Novel compounds useful as sting agonists and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117203194A true CN117203194A (zh) | 2023-12-08 |
Family
ID=83457956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202280023908.7A Pending CN117203194A (zh) | 2021-03-30 | 2022-03-29 | 用作sting激动剂的新型化合物及其用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240116909A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4313962B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024511832A (cg-RX-API-DMAC10.html) |
| CN (1) | CN117203194A (cg-RX-API-DMAC10.html) |
| AR (1) | AR125608A1 (cg-RX-API-DMAC10.html) |
| TW (1) | TW202302579A (cg-RX-API-DMAC10.html) |
| UY (1) | UY39705A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022206725A1 (cg-RX-API-DMAC10.html) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026001915A1 (en) * | 2024-06-24 | 2026-01-02 | Jacobio Pharmaceuticals Co., Ltd. | Drug linker, conjugate thereof, and uses thereof |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250108123A1 (en) * | 2021-12-17 | 2025-04-03 | Jacobio Pharmaceuticals Co., Ltd. | Compound-linker constructs comprising novel compounds useful as sting agonists and uses thereof |
| WO2024032782A1 (en) * | 2022-08-12 | 2024-02-15 | Jacobio Pharmaceuticals Co.Ltd. | Vaccine adjuvants and uses thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10793557B2 (en) | 2018-04-03 | 2020-10-06 | Merck Sharp & Dohme Corp. | Sting agonist compounds |
| US11702430B2 (en) * | 2018-04-03 | 2023-07-18 | Merck Sharp & Dohme Llc | Aza-benzothiophene compounds as STING agonists |
| DK4004002T3 (da) * | 2019-07-22 | 2024-09-30 | Lupin Ltd | Makrocykliske forbindelser som sting-agonister samt fremgangsmåder og anvendelser dermed |
-
2022
- 2022-03-29 US US18/284,897 patent/US20240116909A1/en active Pending
- 2022-03-29 EP EP22778907.0A patent/EP4313962B1/en active Active
- 2022-03-29 UY UY0001039705A patent/UY39705A/es unknown
- 2022-03-29 CN CN202280023908.7A patent/CN117203194A/zh active Pending
- 2022-03-29 TW TW111112050A patent/TW202302579A/zh unknown
- 2022-03-29 WO PCT/CN2022/083557 patent/WO2022206725A1/en not_active Ceased
- 2022-03-29 JP JP2023560282A patent/JP2024511832A/ja active Pending
- 2022-03-29 AR ARP220100748A patent/AR125608A1/es not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026001915A1 (en) * | 2024-06-24 | 2026-01-02 | Jacobio Pharmaceuticals Co., Ltd. | Drug linker, conjugate thereof, and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| AR125608A1 (es) | 2023-08-02 |
| EP4313962B1 (en) | 2026-07-22 |
| TW202302579A (zh) | 2023-01-16 |
| EP4313962A4 (en) | 2025-02-26 |
| UY39705A (es) | 2022-10-31 |
| JP2024511832A (ja) | 2024-03-15 |
| WO2022206725A1 (en) | 2022-10-06 |
| EP4313962A1 (en) | 2024-02-07 |
| US20240116909A1 (en) | 2024-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11008305B2 (en) | DNA-PK inhibitors | |
| AU2016225896B2 (en) | Heterocyclic compounds useful as PDK1 inhibitors | |
| CN114286818B (zh) | 作为bet抑制剂的杂环化合物 | |
| KR102041442B1 (ko) | 중수소화된 디아미노피리미딘 화합물 및 이 화합물을 함유하는 약물 조성물 | |
| CA2927392C (en) | Dna-pk inhibitors | |
| CA2409743C (en) | Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors | |
| TWI829112B (zh) | Sting(干擾素基因刺激物)之調節劑 | |
| CN114423751B (zh) | 用作选择性aurora a抑制剂的新型杂环化合物 | |
| JP2021512158A (ja) | Ｒｈｏ関連プロテインキナーゼのモジュレーター | |
| WO2017024013A1 (en) | 3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof | |
| US9675606B2 (en) | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors | |
| EP4313962A1 (en) | Novel compounds useful as sting agonists and uses thereof | |
| CN117242056A (zh) | 用作sting激动剂的新型化合物及其用途 | |
| CN115109061B (zh) | 三环化合物 | |
| KR20230011981A (ko) | 치환된 트리사이클릭 아미드, 이의 유사체, 및 이를 사용하는 방법 | |
| WO2023104043A1 (zh) | 一种抗凋亡蛋白bcl-2抑制剂、药物组合物及其应用 | |
| WO2019196918A1 (zh) | 五元杂环并嘧啶类化合物、药物组合物及用途 | |
| HK40105275A (en) | Novel compounds useful as sting agonists and uses thereof | |
| CN117321055A (zh) | Sting(干扰素基因刺激剂)的调节剂 | |
| HK40066473B (en) | Novel heterocyclic compounds useful as aurora a selective inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |